Edition:
United Kingdom

Fresenius Medical Care AG & Co KGaA (FMEG.DE)

FMEG.DE on Xetra

70.16EUR
18 Apr 2019
Change (% chg)

€-1.22 (-1.71%)
Prev Close
€71.38
Open
€71.00
Day's High
€71.04
Day's Low
€69.84
Volume
1,727,065
Avg. Vol
981,807
52-wk High
€91.74
52-wk Low
€55.44

About

Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company's segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the... (more)

Overall

Beta: 0.37
Market Cap(Mil.): €25,665.52
Shares Outstanding(Mil.): 307.96
Dividend: 0.96
Yield (%): 1.15

Financials

  FMEG.DE Industry Sector
P/E (TTM): 20.57 27.86 32.55
EPS (TTM): 4.05 -- --
ROI: 8.40 6.65 13.83
ROE: 13.39 10.55 15.25

Fresenius Medical Care to pay $231 million to resolve criminal, civil foreign bribery charges

Germany-based dialysis clinic operator Fresenius Medical Care AG will pay about $231 million to resolve criminal and civil allegations that the company paid bribes to public health and government officials in several countries to win or retain business, the U.S. Justice Department said on Friday.

29 Mar 2019

UPDATE 2-Fresenius Medical Care to pay $231 mln to resolve criminal, civil foreign bribery charges

March 29 Germany-based dialysis clinic operator Fresenius Medical Care AG will pay about $231 million to resolve criminal and civil allegations that the company paid bribes to public health and government officials in several countries to win or retain business, the U.S. Justice Department said on Friday.

29 Mar 2019

FMC wraps up $2 bln acquisition of NxStage

BERLIN, Feb 22 Germany's Fresenius Medical Care (FMC) wrapped up its $2 billion acquisition of U.S. home dialysis maker NxStage Medical on Friday, according to a U.S. Securities and Exchange Commission filing.

22 Feb 2019

Fresenius flags faster earnings growth from 2020 after investment

BERLIN Fresenius expects earnings to grow faster than sales from 2020 after investments to improve its German hospitals and scale up its home dialysis business eat up profit this year, the German healthcare group said on Wednesday.

20 Feb 2019

FMC expects NxStage deal to close in next couple of days

BERLIN Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

20 Feb 2019

UPDATE 2-Fresenius flags faster earnings growth from 2020 after investment

* Announces 1 bln euros share buyback at Fresenius Medical Care

20 Feb 2019

FMC expects NxStage deal to close in next couple of days

BERLIN, Feb 20 Germany's Fresenius Medical Care (FMC) said on Wednesday it has won the green light from U.S. regulators to acquire U.S. home dialysis equipment maker NxStage and expects the deal to close in the next few days.

20 Feb 2019

RPT-Fresenius Medical Care plans 1 bln eur share buyback

BERLIN, Feb 20 Fresenius Medical Care, the world's biggest provider of dialysis services, signalled a return to profit growth from 2020 on Wednesday and said it would buy back shares worth 1 billion euros ($1.13 billion) over the next two years.

20 Feb 2019

Fresenius Medical Care plans 1 bln eur share buyback

BERLIN, Feb 20 Fresenius Medical Care, the world's biggest provider of dialysis services, signalled a return to profit growth from 2020 on Wednesday and said it would buy back shares worth 1 billion euros ($1.13 billion) over the next two years.

20 Feb 2019

Fresenius expects earnings to stagnate in 2019 as investments weigh

BERLIN, Feb 20 German healthcare group Fresenius said sales growth would slow and profit stagnate this year as investments to fix the performance at its German hospitals business and build up home dialysis take a toll.

20 Feb 2019

Earnings vs. Estimates